Cordance Medical, a pioneer in noninvasive focused ultrasound technology for brain disease treatment, announced an oversubscribed seed financing round led by Sonder Capital. The round surpassed its $8M target and included participation from existing and new investors, including Shanda Grab Ventures, Angel Physician's Fund, SmartGateVC, and R42. The Sontag Foundation Innovation Fund, a subsidiary of The Sontag Foundation, and the Brain Tumor Investment Fund, a venture subsidiary of the National Brain Tumor Society, also joined the round, highlighting the platform's potential impact on neuro-oncology care.